Trends of Lipid Concentrations, Awareness, Evaluation, and Treatment in Severe Dyslipidemia in US Adults.
Mayo Clin Proc
; 99(2): 271-282, 2024 Feb.
Article
in En
| MEDLINE
| ID: mdl-38189687
ABSTRACT
OBJECTIVE:
To evaluate the contemporary trends of lipid concentrations, cholesterol evaluation, hypercholesterolemia awareness, and statin use among individuals with severe dyslipidemia (low-density lipoprotein cholesterol [LDL-C] level ≥190 mg/dL) between 2011 and 2020. PATIENTS ANDMETHODS:
This serial cross-sectional analysis included nonpregnant adults ≥20 years of age from the National Health and Nutrition Examination Survey between 2011 and 2020. Age-adjusted weighted trends of LDL-C, triglycerides, cholesterol evaluation in the past 5 years, hypercholesterolemia awareness, and documented statin use among individuals with severe dyslipidemia were estimated.RESULTS:
Among 24,722 participants included, the prevalence of severe dyslipidemia was 5.4% (SE 0.2%) which was stable across the study period (Ptrend=.78). Among individuals with severe dyslipidemia (mean age 55.3 [SE 0.7] years; 52.2% females; 68.8% non-Hispanic White), LDL-C (224.3 [SE 4.2] mg/dL in 2011-2012 to 224.2 [SE 4.6] mg/dL in 2017-2020; Ptrend =.83), and triglyceride (123.3 [SE 1.1] mg/dL in 2011-2012 to 101.8 [SE 1.1] mg/dL in 2017-2020; Ptrend=.13), levels remained stable from 2011 to 2020. The rates of cholesterol evaluation in the past 5 years (72.0% [SE 5.7%] in 2011-2012 to 78.0% [SE 4.8%] in 2017-2020; Ptrend=.91), hypercholesterolemia awareness (48.1% [SE 5.5%] in 2011-2012 to 51.9% [SE 5.8%] in 2017- 2020; Ptrend=.77), and documented statin use (34.7% [SE 4.5%] in 2011-2012 to 33.4% [SE 4.0%] in 2017-2020; Ptrend=.28) remained stagnant in individuals with severe dyslipidemia between 2011 and 2020.CONCLUSION:
Among individuals with severe dyslipidemia, cholesterol evaluation and hypercholesterolemia awareness rates were stable at â¼75% and â¼50% in the past decade. Only â¼34% of individuals with severe dyslipidemia took statins between 2011 and 2020, which likely contributed to the stable LDL-C levels noted across the study period. Further investigations into the determinants of statin use and adherence to statins are needed.
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Hydroxymethylglutaryl-CoA Reductase Inhibitors
/
Dyslipidemias
/
Hypercholesterolemia
/
Hyperlipidemias
Type of study:
Observational_studies
/
Prevalence_studies
/
Risk_factors_studies
Limits:
Adult
/
Female
/
Humans
/
Male
/
Middle aged
Language:
En
Journal:
Mayo Clin Proc
/
Mayo clin. proc
/
Mayo clinic proceedings
Year:
2024
Document type:
Article
Affiliation country:
Estados Unidos
Country of publication:
Reino Unido